What is preventing the French pharmaceutical group and U.S. biotech from reaching a merger agreement?
Continue reading Still No Deal Between Sanofi-Aventis and Genzyme
Still No Deal Between Sanof…
A basket case for so long, Japan is actually showing glimmers of economic progress. It’s in the right place to offer investors access to Asia’s booming emerging markets while also providing a stable, safe-haven platform for ent…
Why is that so — when the average worker hasn’t enjoyed even a small raise? That’s because Wall Street enjoys at least four major advantages that other industries can only dream about, including an implied backstop against los…
Union employees at Chrysler Group will receive a $750 bonus next week as an acknowledgment of their contributions in helping to revive the once-bankrupt company, the automaker said Monday. Salaried workers, excluding the compan…
RPX has been in business since just 2008, but it has rapidly built a list of big-name clients attracted to its novel service. It offers tech companies a way to gain access to patents without having to own them outright — and w…